Conditions: Inflammation Pain
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 406
Healthy volunteers: no

Brief summary:
This study is being conducted to compare the safety and efficacy of loteprednol etabonate compared to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.

Detailed description:

Arms:
arm 1: Loteprednol etabonate arm 2: Vehicle of loteprednol etabonate

Interventions: intervention 1: Vehicle of Loteprednol Etabonate intervention 2: Loteprednol Etabonate
Intervention descriptions: intervention 1: 1 to 2 drops of vehicle administered into the study eye, 4 times a day for approximately 14 days. intervention 2: 1 to 2 drops of study drug administered into the study eye, 4 times a day for approximately 14 days.

Protocol document: